WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹15 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr | ₹-108 Cr |
What is the latest Cash Flow from Financing Activities ratio of WANBURY ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹15 Cr |
Mar2023 | ₹-32 Cr |
Mar2022 | ₹-29 Cr |
Mar2021 | ₹-17 Cr |
Mar2020 | ₹-108 Cr |
How is Cash Flow from Financing Activities of WANBURY Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹15 Cr | Positive | |
Mar2023 | ₹-32 Cr | Negative | |
Mar2022 | ₹-29 Cr | Negative | |
Mar2021 | ₹-17 Cr | Negative | |
Mar2020 | ₹-108 Cr | - |
Compare Cash Flow from Financing Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹775.6 Cr | -1.7% | -11.6% | 65.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,135.0 Cr | 2.6% | -1.1% | 38.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,074.0 Cr | -3.8% | -1.9% | 60.1% | Stock Analytics | |
CIPLA | ₹114,019.0 Cr | -2.4% | -5.2% | 10.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,192.0 Cr | -5.9% | -9.6% | 14.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,256.3 Cr | -3.9% | -0.3% | 40.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -1.7% |
-11.6% |
65.4% |
SENSEX | -0.6% |
-2.9% |
6.3% |
You may also like the below Video Courses